Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 17, 2020 03:09 ET | Source: Zealand Pharma

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

Company announcement – No. 63 / 2020 Copenhagen, December 17, 2020 – Zealand Pharma A/S (“Zealand”) (Nasdaq: ZEAL) (CVR-no. 20045078) has received information on transactions in Zealand's shares or...
December 15, 2020 08:22 ET | Source: Zealand Pharma

Zealand Pharma announces data from the first phase 3-trial with dasiglucagon in Congenital Hyperinsulinism (CHI)

Company announcement – No. 62 / 2020 Dasiglucagon on top of standard of care (SOC) did not significantly reduce the rate of hypoglycemia compared to SOC alone when assessed by intermittent...
December 14, 2020 04:10 ET | Source: Zealand Pharma

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

Company announcement – No. 61 / 2020 Copenhagen, December 14, 2020 – Zealand Pharma A/S (“Zealand”) (Nasdaq: ZEAL) (CVR-no. 20045078) has received information on transactions in Zealand's shares or...
December 11, 2020 09:04 ET | Source: Zealand Pharma

Zealand Pharma increases its share capital as a consequence of exercise of employee warrants

Company announcement – No. 60 / 2020 Copenhagen, December 11, 2020 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the...
December 11, 2020 08:00 ET | Source: Zealand Pharma

Financial calendar for Zealand Pharma in 2021

Company announcement – No. 59 / 2020 Copenhagen, December 11, 2020 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the...
December 09, 2020 09:08 ET | Source: Zealand Pharma

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

Company announcement – No. 58 / 2020 Copenhagen, December 9, 2020 – Zealand Pharma A/S (“Zealand”) (Nasdaq: ZEAL) (CVR-no. 20045078) has received information on transactions in Zealand's shares or...
November 30, 2020 03:09 ET | Source: Zealand Pharma

Total number of shares and voting rights in Zealand Pharma at November 30, 2020

Company announcement – No. 57 / 2020 Copenhagen, November 30, 2020 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the...
November 25, 2020 06:32 ET | Source: Zealand Pharma

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

Company announcement – No. 56 / 2020 Copenhagen, November 25, 2020 – Zealand Pharma A/S (“Zealand”) (Nasdaq: ZEAL) (CVR-no. 20045078) has received information on transactions in Zealand's shares or...
November 20, 2020 07:29 ET | Source: Zealand Pharma

Zealand Pharma increases its share capital as a consequence of exercise of employee warrants

Company announcement – No. 55 / 2020 Copenhagen, November 20, 2020 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the...
November 12, 2020 09:00 ET | Source: Zealand Pharma

Zealand Pharma continues to advance clinical programs and commercial launch capabilities and presents financial results for the first nine months of 2020

Interim report for 9M 2020 Financial results for the first nine months of 2020 Revenue: DKK 290.0 million / USD 45.6 million (DKK 29.8 million / USD 4.4 million in the first nine months of...